On the HCPLive Internal Medicine condition center page, resources on the topics of medical news and expert insight into internal medicine can be found. Content includes articles, interviews, videos, podcasts, and breaking news on internal medicine research, treatment, and drug development.
February 7th 2025
Emblaveo combines aztreonam, a monobactam antibiotic, and avibactam, a β-lactamase inhibitor.
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management
April 3, 2025
Register Now!
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
Clinical ShowCase™: Forming a Personalized Treatment Plan for a Patient With ANCA-Associated Vasculitis
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
View More
Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)
View More
Advances In: Managing Hyperphosphatemia in Chronic Kidney Disease – Bridging Treatment Gaps With Novel Therapies
View More
Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis
View More
Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis
View More
Treatment Strategies in Hepatitis C
January 24th 2013The most important treatment outcome in hepatitis C is sustained virological response, due to its impact on reducing the risks of liver-related mortality, hepatocellular carcinoma, and hepatic decompensation. The degree of baseline liver disease, IL28B genotype, and HCV genotype are important determinants of response to treatment.
Early Detection and Treatment is the Key to Increasing Survival in Patients with Liver Cancer
January 20th 2013Hepatocellular carcinoma is the fastest rising cause of cancer-related deaths in the United States. However, there are several stages along the way from healthy liver to malignant transformation that offer opportunities for detection and intervention.
New Research Is Changing the Clinical Perception of Chronic Pancreatitis
January 20th 2013Researchers have identified several mutations of genes that could predispose someone to chronic pancreatitis, while thinking has also changed when it comes to treating the pain associated with this chronic condition.
Assessment, Diagnosis, and Management of Celiac Disease
January 19th 2013With celiac disease becoming more prevalent, especially in adults, what are the most effective approaches to testing patients for this disease, and are there effective management strategies that can be used in conjunction with a gluten-free diet?
Product News: Linzess for Irritable Bowel Syndrome with Constipation
January 17th 2013Linzess (linaclotide capsules) was approved in August 2012 by the FDA as a once-daily treatment for adult men and women suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC).
Why REMS for Extended-Release/Long-Acting Opioids May NOT Matter
January 14th 2013The Canadian government's recent decision to allow the sale of a generic version of the original formulation of OxyContin could have serious consequences for efforts to curb opioid abuse, misuse, and diversion in the US.
Assessing the Effectiveness of Psycho-Social Interventions in Reducing Symptom Severity in IBS
January 10th 2013Recent study results suggest that treatment that includes patient education, cognitive behavioral therapy, and other psycho-social modalities can help reduce symptom severity and improve quality of life in patients with irritable bowel syndrome (IBS).
Drug-eluting Stents Safer than Bare-metal Stents for Coronary Bypass
Researchers have found that "coronary bypass surgery may carry less risk of serious complications if stents coated with a drug that suppresses cell growth are used in the procedure rather than bare-metal stents."